Variceal bleeding in primary biliary cirrhosis patients: A subgroup with improved prognosis and a model to predict survival after first bleeding

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 6, 2009, Pages 701-707

  Vlachogiannakos, Jiannis ^a   Carpenter, James ^b   Goulis, John ^a   Triantos, Christos ^a   Patch, David ^a   Burroughs, Andrew K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Multivariable proportional hazard model; Primary biliary cirrhosis; Survival; Variceal bleeding

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; VASOACTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; BLEEDING; CAUSE OF DEATH; CONTROLLED STUDY; DRUG TREATMENT FAILURE; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS TRANSECTION; EXPERIMENTAL MODEL; FATIGUE; FEMALE; HAZARD RATIO; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTOCAVAL SHUNT; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; SURVIVAL; SYMPTOMATOLOGY; TREATMENT RESPONSE; VARIX BLEEDING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BILIRUBIN; EPIDEMIOLOGIC METHODS; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; JAUNDICE; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PROGNOSIS;

EID: 67649798643     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328320005f     Document Type: Article

References (35)

1. Neuberger J. Primary biliary cirrhosis. Lancet 1997; 350:875-879.
2. Hughes MD, Raskino CL, Pocock SJ, Biagini MR, Burroughs AK. Prediction of short-term survival with an application in primary biliary cirrhosis. Stat Med 1992; 11:1731-1745.
3. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989; 10:1 -7.
4. Christensen E, Altman DG, Neuberger J, DeStavola BL, Tygstrup N, Williams R, and the PBC1 and PBC2 Trial Groups. Updating prognosis in primary biliary cirrhosis using a time-dependent cox regression model. Gastroenterology 1993; 105:1865-1876.
5. Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979; 20:137-140.
6. Devlin J, O'Grady J. Indications for referral and assessment in adult liver transplantation: a clinical guidance. Gut 1999; 45 (Suppl Vl):1 -22.
7. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973; 289:674-678.
8. Levy C, Zein CO, Gomez J, Soldevila-Pico C, Firpi R, Morelli G, et aL. Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007; 5:803-808.
9. Takeshita E, Kumagi T, Matsui H, Abe M, Furukawa S, Ikeda Y, ef a/. Esophagogastric varices as a prognostic factor for the determination of clinical stage in patients with primary biliary cirrhosis. J Gastroenterol 2003; 38:1060-1065.
10. Murata Y, Abe M, Furukawa S, Kumagi T, Matsui H, Matsuura K, etal. Clinical features of symptomatic primary biliary cirrhosis initially complicated with esophageal varices. J Gastroenterol 2006; 41:1220-1226.
11. Goudie BM, Burt AD, Macfarlane GJ, Boyle P, Gillis CR, Mac Sween NM, et al. Risk factors and prognosis in primary biliary cirrhosis. Am J Gastroenterol 1989; 84:713-716.
12. Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 1990; 25:119-126.
13. Bonsel GJ, Klompmaker IJ, Van't Veer F, Habbema DF, Slooff MJ. Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis. Lancet 1990; 335:493-497.
14. Zeegen R, Stansfeld AG, Dawson AM, Hunt AH. Bleeding oesophageal varices as the presenting feature in primary biliary cirrhosis. Lancet 1969; 2:9-13.
15. Colina F, Pinedo F, Solis JA, Moreno D, Nevado M. Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis. Gastroenterology 1992; 102:1319-1324.
16. Navasa M, Pares A, Bruguera M, Caballeria J, Bosch J, Rodes J. Portal hypertension in primary biliary cirrhosis. Relationship with histological features. J Hepatol 1987; 5:292-298.
17. Roll J, Boyer J, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983; 308:1 -7.
18. Sherlock S. Primary biliary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology 1959; 37:574-586.
19. Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med 1967; 60:1257-1260.
20. Therneau TM, Grambsch PM. Modeling survival data. New York: Springer-Verlag; 2000.
21. Burroughs AK, Hamilton G, Phillips A, Mezzanotte G, Mclntyre N, Hobbs KEF. A comparison of sclerotherapy with staple transaction of the oesophagus for the emergency control of bleeding from oesophageal varices. N Engl J Med 1989; 321:857-866.
22. Ben-Ari Z, Cardin F, McCormick AP, Wannamethee G, Burroughs AK. A predictive model for failure to control bleeding during acute variceai haemorrhage. J Hepatol 1999; 31:443-450.
23. Kew MC, Varma RR, Dos Santos HA, Scheuer PJ, Sherlock S. Portal hypertension in primary biliary cirrhosis. Gut 1971; 12:830-834.
24. Thornton JR, Triger DR, Losowsky MS. Variceai bleeding is associated with reduced risk of severe cholestasis in primary biliary cirrhosis. O J Med 1989; 69:467-471.
25. Gores GJ, Wiesner RH, Dickson ER, Zinmeister AR, Jorgensen RA, Langworthy A. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. Gastroenterology 1989; 96:1552-1559.
26. Lebrec D, Sicot C, Degott C, Benhamou JP. Portal hypertension and primary biliary cirrhosis. Digestion 1976; 14:220-226.
27. Prince M, Chetwynd A, Newman W, Metcalf JV, James OFW. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 2002; 123:1044-1051.
28. El-Serag HB, Everhart JE. Improved survival after variceai hemorrhage over an 11 -year period in the department of Veterans Affairs. Am J Gastroenterol 2000; 95:3566-3573.
29. McCormick PA, O'Keefe C. Improving prognosis following a first variceai hemorrhage over four decades. Guf 2001; 49:682-685.
30. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceai bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98:653-659.
31. D'Amico G, De Franchis R, and a Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38:599-612.
32. Resnik RH, Iber FL, Ishihara AM, Chalmas TC, Zimmerman H. A controlled study of the therapeutic portocaval shunt. Gastroenterology 1974; 67: 843-857.
33. Sepersky R, Callow A, Kanel G, Kaplan M. Portosystemic shunts in primary biliary cirrhosis. Survival is the same as in patients with Laennec's cirrhosis and postnecrotic cirrhosis. Dig Dis Sci 1982; 27:507-512.
34. Prince Ml, Jones DE. Primary biliary cirrhosis: new perspectives in diagnosis and treatment. Postgrad Med J 2000; 76:199-206.
35. Goulis J, Leandro G, Burroughs AK. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 1999; 354:1054-1060.